Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.63M | -9.17M | -11.21M | -14.54M | -17.26M |
| Total Depreciation and Amortization | 783.00K | 719.00K | 655.00K | 576.00K | 556.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.50M | 3.97M | 4.15M | 4.78M | 5.14M |
| Change in Net Operating Assets | -6.77M | -3.40M | -1.59M | 773.00K | 2.26M |
| Cash from Operations | -10.13M | -7.87M | -8.00M | -8.41M | -9.31M |
| Capital Expenditure | -920.00K | -1.12M | -1.11M | -1.08M | -718.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -920.00K | -1.12M | -1.11M | -1.08M | -718.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.00K | -20.00K | -20.00K | -19.00K | -20.00K |
| Issuance of Common Stock | 9.88M | 9.88M | 9.79M | 7.05M | 7.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -248.00K | -218.00K | -188.00K | -175.00K | -175.00K |
| Cash from Financing | 9.61M | 9.64M | 9.58M | 6.86M | 6.81M |
| Foreign Exchange rate Adjustments | -244.00K | -522.00K | -466.00K | -241.00K | -152.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.68M | 126.00K | -1.00K | -2.88M | -3.38M |